Current tests for the initial diagnosis of prostate cancer have limited sensitivity and specificity, and new biomarkers are being investigated. This Review discusses the use of molecular techniques for research into gene expression in prostate cancer and the biomarkers identified that could prove to be useful in the diagnosis and categorization of prostate cancer.
- Colin S Cooper
- Colin Campbell
- Sameer Jhavar
